Guardant Health Inc. (GH)
43.01
-2.14 (-4.74%)
At close: Mar 28, 2025, 2:40 PM
Guardant Health Income Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
| Revenue | 739.02M | 563.95M | 449.54M | 373.65M | 286.73M | 214.38M | 90.64M | 49.84M | 25.25M |
| Cost of Revenue | 289.8M | 227.05M | 156.32M | 122.91M | 92.53M | 70.72M | 43.21M | 31.62M | 22.12M |
| Gross Profit | 449.22M | 336.9M | 293.21M | 250.74M | 194.19M | 143.66M | 47.43M | 18.22M | 3.13M |
| Operating Income | -443.59M | -564.73M | -544.38M | -411M | -254.95M | -82.37M | -92.94M | -76.61M | -43.85M |
| Interest Income | 53.69M | 35.37M | 6.07M | 3.93M | 10.17M | 13.74M | 5.27M | 2.23M | 733K |
| Pretax Income | -435.09M | -478.76M | -653.45M | -384.47M | -245.9M | -69.72M | -84.22M | -83.21M | -46.13M |
| Net Income | -436.37M | -479.45M | -654.59M | -384.77M | -246.28M | -67.85M | -85.06M | -83.22M | -46.14M |
| Selling & General & Admin | 545.06M | 451.03M | 463.78M | 398.52M | 299.28M | 139.73M | 89.66M | 69.27M | 36.11M |
| Research & Development | 347.75M | 367.19M | 373.81M | 263.22M | 149.86M | 86.29M | 50.71M | 25.56M | 10.86M |
| Other Expenses | n/a | 83.4M | -112.56M | 25.18M | 3.64M | 88K | 4.7M | -1.06M | -1K |
| Operating Expenses | 892.81M | 901.62M | 837.59M | 661.74M | 449.14M | 226.03M | 140.37M | 94.84M | 46.97M |
| Interest Expense | 2.58M | 2.58M | 2.58M | 2.58M | 4.77M | 1.18M | 1.25M | 2.7M | 3.02M |
| Selling & Marketing Expenses | 364.94M | 295.23M | 299.83M | 191.88M | 106.51M | 78.33M | 53.47M | 32.5M | 26.19M |
| Cost & Expenses | 1.18B | 1.13B | 993.92M | 784.65M | 541.68M | 296.75M | 183.58M | 126.45M | 69.1M |
| Income Tax | 1.28M | 685K | 1.14M | 300K | 379K | -1.87M | 38K | 7K | 6K |
| Shares Outstanding (Basic) | 122.75M | 111.99M | 102.18M | 101.31M | 97.5M | 90.6M | 30.4M | 70.72M | 70.72M |
| Shares Outstanding (Diluted) | 122.75M | 111.99M | 102.18M | 101.31M | 97.5M | 90.6M | 30.4M | 70.72M | 70.72M |
| EPS (Basic) | -3.56 | -4.28 | -6.41 | -3.8 | -2.53 | -0.75 | -2.8 | -1.18 | -0.65 |
| EPS (Diluted) | -3.56 | -4.28 | -6.41 | -3.8 | -2.53 | -0.75 | -2.8 | -1.18 | -0.65 |
| EBITDA | -390.12M | -433.31M | -614.91M | -359.62M | -225.07M | -54.93M | -75.84M | -75.31M | -39.42M |
| Depreciation & Amortization | 42.39M | 42.88M | 35.96M | 22.27M | 16.07M | 13.61M | 7.14M | 5.21M | 3.69M |